MENU
+Compare
VNDA
Stock ticker: NASDAQ
AS OF
Mar 10, 04:59 PM (EDT)
Price
$4.71
Change
-$0.13 (-2.68%)
Capitalization
282.83M

VNDA Vanda Pharmaceuticals Forecast, Technical & Fundamental Analysis

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients... Show more

Industry: #Biotechnology
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for VNDA with price predictions
Mar 04, 2025

Momentum Indicator for VNDA turns positive, indicating new upward trend

VNDA saw its Momentum Indicator move above the 0 level on February 28, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 102 similar instances where the indicator turned positive. In of the 102 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for VNDA just turned positive on February 26, 2025. Looking at past instances where VNDA's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

VNDA moved above its 50-day moving average on February 26, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VNDA advanced for three days, in of 262 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 10-day moving average for VNDA crossed bearishly below the 50-day moving average on February 21, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VNDA broke above its upper Bollinger Band on February 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VNDA entered a downward trend on February 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VNDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.525) is normal, around the industry mean (11.742). P/E Ratio (137.000) is within average values for comparable stocks, (66.249). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.790). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (1.419) is also within normal values, averaging (229.516).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VNDA is expected to report earnings to fall 75.00% to -1 cents per share on April 30

Vanda Pharmaceuticals VNDA Stock Earnings Reports
Q1'25
Est.
$-0.02
Q4'24
Beat
by $0.09
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.05
Q1'24
Missed
by $0.12
The last earnings report on February 13 showed earnings per share of -7 cents, beating the estimate of -17 cents. With 207.67K shares outstanding, the current market capitalization sits at 282.83M.
A.I. Advisor
published General Information

General Information

a manufacturer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2200 Pennsylvania Avenue NW
Phone
+1 202 734-3400
Employees
203
Web
https://www.vandapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

VNDA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with IKNA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
+1.91%
IKNA - VNDA
37%
Loosely correlated
+4.65%
SNGX - VNDA
32%
Poorly correlated
N/A
ATRA - VNDA
30%
Poorly correlated
+1.86%
CLDX - VNDA
29%
Poorly correlated
+3.36%
FHTX - VNDA
28%
Poorly correlated
+1.62%
More